PubRank

Chang-Gong Liu

Author PubWeight™ 335.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006 40.09
2 MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 27.56
3 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006 23.59
4 miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005 21.51
5 MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004 14.59
6 MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008 12.26
7 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007 9.97
8 MicroRNA signatures in human ovarian cancer. Cancer Res 2007 9.45
9 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005 8.60
10 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008 7.56
11 A microRNA signature of hypoxia. Mol Cell Biol 2006 7.24
12 Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006 5.72
13 MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 2005 5.54
14 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006 5.40
15 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007 5.40
16 MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008 5.23
17 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008 5.16
18 MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008 4.91
19 Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 2008 4.79
20 Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 4.50
21 MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008 4.33
22 Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 2008 4.26
23 Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 2008 4.09
24 Retracted A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009 3.88
25 MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 2006 3.80
26 FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007 3.46
27 Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005 3.35
28 MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009 3.29
29 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008 3.16
30 MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008 3.06
31 MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009 3.03
32 MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 2008 2.97
33 p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011 2.93
34 EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 2013 2.67
35 Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010 2.65
36 High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 2008 2.63
37 Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 2008 2.61
38 Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008 2.56
39 Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008 2.56
40 MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 2007 2.53
41 MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008 2.35
42 Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res 2012 2.27
43 Time course analysis of gene expression during light-induced photoreceptor cell death and regeneration in albino zebrafish. Dev Neurobiol 2007 2.18
44 Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009 2.09
45 Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 2008 1.87
46 Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008 1.86
47 Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008 1.86
48 A comparison of normalization techniques for microRNA microarray data. Stat Appl Genet Mol Biol 2008 1.82
49 The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest 2013 1.76
50 Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 2008 1.75
51 Functional analysis of microRNAs in human hepatocellular cancer stem cells. J Cell Mol Med 2012 1.35
52 Retracted Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009 1.33
53 MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 2009 1.33
54 Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 2010 1.30
55 Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010 1.26
56 MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res 2011 1.26
57 MicroRNA expression profiling of male breast cancer. Breast Cancer Res 2009 1.22
58 Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 2011 1.14
59 FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1. Mol Cell 2011 1.14
60 Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol 2012 1.10
61 Plasma microRNA profiles for bladder cancer detection. Urol Oncol 2012 1.09
62 Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans. Carcinogenesis 2002 1.03
63 Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J Biol Chem 2009 1.02
64 Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology 2008 1.02
65 Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013 1.01
66 Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol 2011 1.00
67 Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data. PLoS One 2012 0.99
68 Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids. Nucleic Acids Res 2005 0.97
69 Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol 2013 0.96
70 Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur J Immunol 2014 0.91
71 BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo. Clin Cancer Res 2008 0.91
72 GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res 2010 0.91
73 Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs. J Immunol 2010 0.87
74 MicroRNA profiles of drug-resistant myeloma cell lines. Acta Haematol 2010 0.86
75 miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. J Mol Cell Cardiol 2013 0.82
76 Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells. Biochem Pharmacol 2013 0.81
77 Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol 2006 0.80
78 Global gene expression profiling of cells overexpressing SMC3. Mol Cancer 2005 0.80
79 Compatible solutes from hyperthermophiles improve the quality of DNA microarrays. BMC Biotechnol 2007 0.78
80 A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor. Cell Cycle 2010 0.77
81 An Overview of Chromatin-Regulating Proteins in Cells. Curr Protein Pept Sci 2016 0.75
82 Retraction: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2016 0.75